Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000474401 | SCV000544806 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318522 | SCV000851510 | likely benign | Inborn genetic diseases | 2018-06-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000731064 | SCV000858835 | uncertain significance | not provided | 2018-01-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000731064 | SCV001148738 | uncertain significance | not provided | 2018-12-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000731064 | SCV001940642 | benign | not provided | 2020-06-17 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000731064 | SCV001800454 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000731064 | SCV001970831 | uncertain significance | not provided | no assertion criteria provided | clinical testing |